Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
Summary
- Conditions
- Liver Transplantation
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Prospective, randomized, multi-center study to show safe and effective use of whole liver preservation via hypothermic machine perfusion (HMP) as compared to livers preserved by static cold storage.
Prospective, randomized, multi-center study to show safe and effective use of whole liver preservation via hypothermic machine perfusion (HMP) as compared to livers preserved by static cold storage.
Tracking Information
- NCT #
- NCT03484455
- Collaborators
- Not Provided
- Investigators
- Study Director: Stan Harris Organ Recovery Systems Study Chair: Matthew Copithorne Organ Recovery Systems
Get Well Soon